Salcaprozate is a synthetic drug within the benzoxazine derivative class, primarily recognized for its role as an antihypertensive agent that functions by inhibiting angiotensin-converting enzyme (ACE)… Read more

![Chemical structure of 3-(6-Bromohexyl)-2H-benzo[e][1,3]oxazine-2,4(3H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1452863-52-3-3-6-Bromohexyl-2H-benzoe13oxazine-243H-dione.png&w=3840&q=75)





![Chemical structure of Ethyl 8-(2,4-dioxo-2H-benzo[e][1,3]oxazin-3(4H)-yl)octanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F287935-37-9-Ethyl-8-24-dioxo-2H-benzoe13oxazin-34H-yloctanoate.png&w=3840&q=75)














Salcaprozate is a synthetic drug within the benzoxazine derivative class, primarily recognized for its role as an antihypertensive agent that functions by inhibiting angiotensin-converting enzyme (ACE) activity. By binding to the enzyme's active site, this compound helps regulate vasoconstriction and reduce blood pressure. For pharmaceutical analysis, this category provides a comprehensive selection of high-quality reference materials essential for stringent quality control and method validation. Laboratories utilize these compounds, including specific impurities such as N-nitroso Salcaprozic acid and various synthetic intermediates, to facilitate precise impurity profiling and regulatory compliance. Furthermore, the inclusion of stable isotope-labelled standards, such as Salcaprozic acid-d4, is critical for the accurate quantification of the drug and its metabolites in complex biological matrices. These reference standards ensure that analytical workflows remain robust, reliable, and capable of maintaining the high-purity requirements necessary for pharmaceutical development and clinical research.